Establishment of Opioid-Induced Rewarding Effects Under Oxaliplatin-and Paclitaxel-Induced Neuropathy in Rats
The rewarding effects of μ-receptor agonists can be suppressed under several pain conditions. We recently showed that clinically used μ-receptor agonists possess efficacies for relieving the neuropathic pain induced by chemotherapeutic drug in rats; however, it is possible that the use of μ-receptor...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2014-01-01
|
| Series: | Journal of Pharmacological Sciences |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861319300465 |
| _version_ | 1818427455803752448 |
|---|---|
| author | Tomohisa Mori Tomoe Kanbara Masato Harumiya Yoshiyuki Iwase Aki Masumoto Sachiko Komiya Atsushi Nakamura Masahiro Shibasaki Toshiyuki Kanemasa Gaku Sakaguchi Tsutomu Suzuki |
| author_facet | Tomohisa Mori Tomoe Kanbara Masato Harumiya Yoshiyuki Iwase Aki Masumoto Sachiko Komiya Atsushi Nakamura Masahiro Shibasaki Toshiyuki Kanemasa Gaku Sakaguchi Tsutomu Suzuki |
| author_sort | Tomohisa Mori |
| collection | DOAJ |
| description | The rewarding effects of μ-receptor agonists can be suppressed under several pain conditions. We recently showed that clinically used μ-receptor agonists possess efficacies for relieving the neuropathic pain induced by chemotherapeutic drug in rats; however, it is possible that the use of μ-receptor agonists may trigger the rewarding effects even under chemotherapeutic drug–induced neuropathic pain. Nevertheless, no information is available regarding whether μ-receptor agonists produce psychological dependence under chemotherapeutic drug–induced neuropathic pain. Therefore, we examined the effects of neuropathy induced by chemotherapeutic drugs on the rewarding effects of morphine, oxycodone, and fentanyl in rats. Repeated treatment with oxaliplatin or paclitaxel produced neuropathy as measured by the von Frey test. Rewarding effects produced by antinociceptive doses of μ-receptor agonists were not suppressed under oxaliplatin- or paclitaxel-induced neuropathy. Furthermore, the morphine-induced increase in the release of dopamine from the nucleus accumbens, which is a critical step in the rewarding effects of μ-receptor agonists, was not altered in paclitaxel-treated rats. These results suggest that the rewarding effects of μ-receptor agonists can still be established under oxaliplatin- or paclitaxel-induced neuropathic pain. Therefore, patients should be carefully monitored for psychological dependence on μ-receptor agonists when they are used to control chemotherapeutic drug-induced neuropathic pain. Keywords:: rewarding effect, oxaliplatin, paclitaxel, neuropathic pain, μ-opioid receptor agonist |
| first_indexed | 2024-12-14T14:46:00Z |
| format | Article |
| id | doaj.art-65800cd82022411ba408d76dc260b2a8 |
| institution | Directory Open Access Journal |
| issn | 1347-8613 |
| language | English |
| last_indexed | 2024-12-14T14:46:00Z |
| publishDate | 2014-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Journal of Pharmacological Sciences |
| spelling | doaj.art-65800cd82022411ba408d76dc260b2a82022-12-21T22:57:17ZengElsevierJournal of Pharmacological Sciences1347-86132014-01-0112614755Establishment of Opioid-Induced Rewarding Effects Under Oxaliplatin-and Paclitaxel-Induced Neuropathy in RatsTomohisa Mori0Tomoe Kanbara1Masato Harumiya2Yoshiyuki Iwase3Aki Masumoto4Sachiko Komiya5Atsushi Nakamura6Masahiro Shibasaki7Toshiyuki Kanemasa8Gaku Sakaguchi9Tsutomu Suzuki10Department of Toxicology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, JapanDepartment of Toxicology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, Japan; Pain & Neurology, Discovery Research Laboratories, Shionogi & Co., Ltd., 1-1, 3-chome, Futaba-cho, Toyonaka, Osaka 561-0825, JapanDepartment of Toxicology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, JapanDepartment of Toxicology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, JapanDepartment of Toxicology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, JapanDepartment of Toxicology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, JapanDepartment of Toxicology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, Japan; Pain & Neurology, Discovery Research Laboratories, Shionogi & Co., Ltd., 1-1, 3-chome, Futaba-cho, Toyonaka, Osaka 561-0825, JapanDepartment of Toxicology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, JapanPain & Neurology, Discovery Research Laboratories, Shionogi & Co., Ltd., 1-1, 3-chome, Futaba-cho, Toyonaka, Osaka 561-0825, JapanPain & Neurology, Discovery Research Laboratories, Shionogi & Co., Ltd., 1-1, 3-chome, Futaba-cho, Toyonaka, Osaka 561-0825, JapanDepartment of Toxicology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, Japan; Corresponding author. suzuki@hoshi.ac.jpThe rewarding effects of μ-receptor agonists can be suppressed under several pain conditions. We recently showed that clinically used μ-receptor agonists possess efficacies for relieving the neuropathic pain induced by chemotherapeutic drug in rats; however, it is possible that the use of μ-receptor agonists may trigger the rewarding effects even under chemotherapeutic drug–induced neuropathic pain. Nevertheless, no information is available regarding whether μ-receptor agonists produce psychological dependence under chemotherapeutic drug–induced neuropathic pain. Therefore, we examined the effects of neuropathy induced by chemotherapeutic drugs on the rewarding effects of morphine, oxycodone, and fentanyl in rats. Repeated treatment with oxaliplatin or paclitaxel produced neuropathy as measured by the von Frey test. Rewarding effects produced by antinociceptive doses of μ-receptor agonists were not suppressed under oxaliplatin- or paclitaxel-induced neuropathy. Furthermore, the morphine-induced increase in the release of dopamine from the nucleus accumbens, which is a critical step in the rewarding effects of μ-receptor agonists, was not altered in paclitaxel-treated rats. These results suggest that the rewarding effects of μ-receptor agonists can still be established under oxaliplatin- or paclitaxel-induced neuropathic pain. Therefore, patients should be carefully monitored for psychological dependence on μ-receptor agonists when they are used to control chemotherapeutic drug-induced neuropathic pain. Keywords:: rewarding effect, oxaliplatin, paclitaxel, neuropathic pain, μ-opioid receptor agonisthttp://www.sciencedirect.com/science/article/pii/S1347861319300465 |
| spellingShingle | Tomohisa Mori Tomoe Kanbara Masato Harumiya Yoshiyuki Iwase Aki Masumoto Sachiko Komiya Atsushi Nakamura Masahiro Shibasaki Toshiyuki Kanemasa Gaku Sakaguchi Tsutomu Suzuki Establishment of Opioid-Induced Rewarding Effects Under Oxaliplatin-and Paclitaxel-Induced Neuropathy in Rats Journal of Pharmacological Sciences |
| title | Establishment of Opioid-Induced Rewarding Effects Under Oxaliplatin-and Paclitaxel-Induced Neuropathy in Rats |
| title_full | Establishment of Opioid-Induced Rewarding Effects Under Oxaliplatin-and Paclitaxel-Induced Neuropathy in Rats |
| title_fullStr | Establishment of Opioid-Induced Rewarding Effects Under Oxaliplatin-and Paclitaxel-Induced Neuropathy in Rats |
| title_full_unstemmed | Establishment of Opioid-Induced Rewarding Effects Under Oxaliplatin-and Paclitaxel-Induced Neuropathy in Rats |
| title_short | Establishment of Opioid-Induced Rewarding Effects Under Oxaliplatin-and Paclitaxel-Induced Neuropathy in Rats |
| title_sort | establishment of opioid induced rewarding effects under oxaliplatin and paclitaxel induced neuropathy in rats |
| url | http://www.sciencedirect.com/science/article/pii/S1347861319300465 |
| work_keys_str_mv | AT tomohisamori establishmentofopioidinducedrewardingeffectsunderoxaliplatinandpaclitaxelinducedneuropathyinrats AT tomoekanbara establishmentofopioidinducedrewardingeffectsunderoxaliplatinandpaclitaxelinducedneuropathyinrats AT masatoharumiya establishmentofopioidinducedrewardingeffectsunderoxaliplatinandpaclitaxelinducedneuropathyinrats AT yoshiyukiiwase establishmentofopioidinducedrewardingeffectsunderoxaliplatinandpaclitaxelinducedneuropathyinrats AT akimasumoto establishmentofopioidinducedrewardingeffectsunderoxaliplatinandpaclitaxelinducedneuropathyinrats AT sachikokomiya establishmentofopioidinducedrewardingeffectsunderoxaliplatinandpaclitaxelinducedneuropathyinrats AT atsushinakamura establishmentofopioidinducedrewardingeffectsunderoxaliplatinandpaclitaxelinducedneuropathyinrats AT masahiroshibasaki establishmentofopioidinducedrewardingeffectsunderoxaliplatinandpaclitaxelinducedneuropathyinrats AT toshiyukikanemasa establishmentofopioidinducedrewardingeffectsunderoxaliplatinandpaclitaxelinducedneuropathyinrats AT gakusakaguchi establishmentofopioidinducedrewardingeffectsunderoxaliplatinandpaclitaxelinducedneuropathyinrats AT tsutomusuzuki establishmentofopioidinducedrewardingeffectsunderoxaliplatinandpaclitaxelinducedneuropathyinrats |